Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences in a deal worth as much as $7.8 billion.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0